Inavya has developed Avatr AI in Medicine Technology. This slide deck provides an overview.

1. July 2023
Introducing
AVATR
Commercial in Confidence.
Inavya Ventures Ltd. London ENGLAND Dec 2022

2. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
60% of Adults
No Cure
Medication, behaviour change,
and surgery can help
DISEASE
Chronic

3. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
25%
unscheduled
readmissions
within 4 weeks
MY PATIENTS”
“too little time for
50%
don’t adhere
to the
Care Plan
85%
of all healthcare
costs are for
chronic disease

4. AVATR:
Personalisation at Scale
● customer engagement & retention
● improved clinical outcomes
● cost savings

5. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
24/7 monitoring
of biosigns
Alerts and
proactive guidance
Reminders for medication
Automates personalised
care plan delivery
Proactive care
Live actionable data
TEXT & VOICE
all major languages
PRIVACY - INTEGRATION - SECURITY
fully compliant
AUGMENTED
INTELLIGENCE
LOVED BY
PATIENTS
TRUSTED BY
CLINICIANS
AVATR: AI Toolset
Symbolic AI - Semantic technologies
User-focused design
Multi-factoral, Real-world data

7. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2021
RED
AMBER
GREEN
augmented
intelligence
Patient
ledger
Physician
designed
protocols
ACTIONABLE
DECISION
PATIENT RESPONSE
AUTOMATED
“PAPERWORK”
BENEFITS:
Save Time & Costs*
Improve Clinical Outcomes
Retain Customers
Generate Revenue
AVATR: enabling healthcare transformation
*20% efficiency savings

8. AVATR: Management Dashboard

9. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
Growth
Technology
Design
Michael Wilkinson PhD
Founder & CEO
NHS, LSHTM, Rush Hospital
Aleardo Furlani
Founder & Director
Innova, Gemini
Della Burnside
Director
McDonald’s, EasyGroup
Jack Tang
Director
FisherBroyles, King & Wood Mallesons
Alessio Gugliotta PhD
AI & Architecture
EU COMPOSE
Edoardo Gazzella
App development & Data Analytics
Innova
Marko Vujasinovic PhD
AI & Security
EU COMPOSE, US Standards Agency
Jaspal Sahota PhD
AI, Mathematics & Philosophy
Berkshire Hathaway
John Walters
UX & Design
Isobar, Ogilvy, Cheil
Chris da Costa
UX & Communication
Isobar, Digitas, Publicis
Dr Fabian Emrich
Cardiothoracic Surgeon
Frankfurt University Hospital /
Stamford Medical
Medicine
Thomas Szczepaniak
Investor Relations Advisor
Compass Ventures
Investment
AVATR Team

10. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
AVATR Ecosystem
service - research - education

11. Improvements for
Patients Using Avatr
Technology
AVATR Published Results

12. Commercial in Confidence. All rights reserved. Inavya Ventures Ltd. London. 2022
AVATR Testimonials
Prof. Prakash Punjabi
Professor at National Heart
and Lung Institute.
Fellow Royal College of Surgeons.
Imperial College London
“AVATR’s unique
personalised AI delivers
the perfect remote Care
Plan solution for patients
with chronic diseases from
all ethnic background.”
Lucy Leese
Cardiology Nurse
Leeds Teaching Hospitals
Dr. Luiz Bortolotto
Director Hypertension Unit
Professor Cardiology Department
Sao Paulo University Hospital
“AVATR provides a
significant improvement in
the multidisciplinary care
of our patients and
transform
our clinical approach in
the practice routine.”
Dr. Philip Wong
Senior Consultant Cardiology
Deputy Director
National Heart Research Institute Singapore
“AVATR integrates with
wearable medical devices
such a Spyder ECG.
This provides enhanced
actionable insight for
clinicians to provide
remote healthcare.”
“AVATR is a great time-
saving tool that still
enables me to provide
good quality support. I’m
able to access several
patients, enabling me to
follow their success.”